Search Results for "Fix Combination Travoprost Brinzolamide"
Original Source: Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
The purpose of the study is to determine whether combination of brinzolamide and brimonidine is safe and effective in patients with open-angle glaucoma or ocular hypertension.
Matching Channels
Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate immune system. TLRs have become attractive targets for activation or antagonism in pharmaceutical research. TLR ag...
ZALTRAP®, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed followin...
Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...
BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...
On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...
Matching News
Brinzolamide/Brimonidine Combo Lowers Intraocular Pressure
The combination of 1% brinzolamide with 0.2% brimonidine was safe and effective for reducing intraocular pressure (IOP) in a phase III multicenter study. Reuters Health Information
Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysi...
Travoprost in the Treatment of Ocular Hypertension
What is the most effective dosing strategy of travoprost for the treatment of ocular hypertension? This new study compares daily vs alternate day use. Journal of Glaucoma
Phase II study for travoprost punctum plugs
Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost punctum plug for treating ocular hypertension and glaucoma.
Travoprost punctum plug promising for glaucoma
Ocular Therapeutix Inc. has announced initial results of a feasibility study of a sustained-release travoprost-loaded punctum plug (OPX-TP1) for the treatment of glaucoma.
Ocular begins pilot Phase II travoprost punctum plug trial
Ocular Therapeutix has announced a pilot Phase II trial to examine a two-month sustained release drug, OTX-TP2, for the treatment of ocular hypertension and glaucoma, following successful travoprost p...
Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma
Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical trial to examine a two-month sustained release...
Ocular Therapeutix announces results from sustained release OTX-TP1 study on glaucoma
Ocular Therapeutix, Inc. announced today initial results of their sustained release travoprost-loaded punctum plug feasibility study for the treatment of glaucoma. This travoprost punctum plug (OTX-T...
Matching PubMed Articles
Purpose: The purpose of this study is to examine the changes of the retina and the intrinsic survival signals of the retina by brinzolamide (Azopt®) and travoprost (Travatan®) in a rat model of chro...
PURPOSE: To compare the ocular hypotensive effect of bimatoprost plus timolol and travoprost plus timolol fixed combinations in glaucoma patients whose disease was controlled but had not reached their...
The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost.
Abstract Aim: To determine the intraocular pressure (IOP) lowering effect of brinzolamide when added to latanoprost. Materials and methods: Patients who were simultaneously on brinzolamide and latanop...
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.
PURPOSE: To confirm the possible mechanism by which topical prostaglandin antiglaucoma drugs cause a deep superior sulcus. METHODS: Among patients who used bimatoprost (Lumigan), latanoprost (Xalatan)...
Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.
PURPOSE: To compare the drug efficacy of four prostaglandin analogues (PGAs) by bilateral treatment in normal subjects. METHODS: Three consecutive studies comparing latanoprost to three other PGAs (tr...
